Dianthus Therapeutics, Inc. /DE/ Annual Nonoperating Income (Expense) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2023.
  • Dianthus Therapeutics, Inc. /DE/ Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $4.73M, a 374% increase year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $15.8M.
  • Dianthus Therapeutics, Inc. /DE/ annual Nonoperating Income (Expense) for 2023 was $4.62M, a 276% increase from 2022.
  • Dianthus Therapeutics, Inc. /DE/ annual Nonoperating Income (Expense) for 2022 was $1.23M.
  • Dianthus Therapeutics, Inc. /DE/ annual Nonoperating Income (Expense) for 2021 was -$23K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.62M +$3.39M +276% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $1.23M +$1.25M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$23K Jan 1, 2021 Dec 31, 2021 8-K 2023-12-21
2018 $2.45M +$2.21M +937% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-19
2017 $236K +$399K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-19
2016 -$163K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.